Hammad Tashkandi
Overview
Explore the profile of Hammad Tashkandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tashkandi H, Elbaz Younes I
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730632
Myeloproliferative neoplasms (MPNs), including Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Primary Myelofibrosis (PMF), are characterized by the clonal proliferation of hematopoietic stem cells leading to an overproduction of hematopoietic...
2.
Hennawi M, Quadeer F, Pakasticali N, Osman S, Tashkandi H, Hussaini M
Appl Immunohistochem Mol Morphol
. 2024 May;
32(7):305-308.
PMID: 38695552
Introduction: Multiplex polymerase chain reaction (PCR) and next-generation sequencing (NGS) can both be used to identify a neoplastic clonotype by targeting CDR3 and assessing rearrangements in IgH, IgK, IgL, TCR-β,...
3.
Chan O, Al Ali N, Tashkandi H, Ellis A, Ball S, Grenet J, et al.
Blood Adv
. 2024 Jan;
8(5):1075-1083.
PMID: 38170740
Acute myeloid leukemia (AML) is a heterogeneous malignancy with outcomes largely predicted by genetic abnormalities. Mutations of NPM1 are common in AML, occurring in ∼30% of cases, and generally considered...
4.
Moureiden Z, Tashkandi H, Hussaini M
World J Methodol
. 2023 Sep;
13(4):366-372.
PMID: 37771876
Background: Marginal zone lymphoma (MZL) is an indolent non-Hodgkin B cell lymphoma with various architectural pattern including perifollicular, follicular colonization, nodular, micronodular, and diffuse patterns. A sclerotic variant has not...
5.
Zhang L, Shah B, Zhang Y, Tashkandi H, Xiao W, Fernandez-Pol S, et al.
Hum Pathol
. 2023 Mar;
136:1-15.
PMID: 36958463
JAK2 rearrangement (JAK2-R) in acute lymphoblastic leukemia (ALL) is rare and often categorized as B-ALL with BCR::ABL1-like features based on the World Health Organization classification. We report 10 patients with...
6.
Hennawi M, Pakasticali N, Tashkandi H, Hussaini M
Int J Mol Sci
. 2022 Oct;
23(19).
PMID: 36232559
Mixed-phenotype leukemia (MPAL) is a type of acute leukemia in which the blast population shows mixed features of myeloid, T-lymphoid, and/or B-lymphoid differentiation. MPALs are rare and carry a poor...
7.
Tashkandi H, Verdoni A, West M, Yatsenko S, Swerdlow S, Aggarwal N
Am J Clin Pathol
. 2022 Feb;
158(1):112-121.
PMID: 35142790
Objectives: To overcome the challenges associated with molecular and cytogenetic (MG) education in hematopathology (HP), a monthly joint HP/MG conference with specific curricular goals was established and evaluated by the...
8.
Albakri M, Tashkandi H, Zhou L
Cell Transplant
. 2020 Aug;
29:963689720947146.
PMID: 32749152
Hematopoietic stem cell (HSC) transplantation can be a potential cure for hematological malignancies and some nonhematologic diseases. Hematopoietic stem and progenitor cells (HSPCs) collected from peripheral blood after mobilization are...
9.
10.
Tashkandi H, Petrova-Drus K, Batlevi C, Arcila M, Roshal M, Sen F, et al.
Cold Spring Harb Mol Case Stud
. 2019 Aug;
5(6).
PMID: 31395597
Clonal heterogeneity and evolution of mantle cell lymphoma (MCL) remain unclear despite the progress in our understanding of its biology. Here, we report a 71-yr-old male patient with an aggressive...